New Regulatory Trends for ProbioticsPrevot, Michela BiancoJournal of Clinical Gastroenterology: July 2004 - Volume 38 - Issue - p S61-S63 doi: 10.1097/01.mcg.0000128733.79515.c4 Probiotics, Prebiotics, and New Foods Buy Abstract Author InformationAuthors Article MetricsMetrics The aim of this paper (presented in Rome, Italy, at the 2nd Congress of Probiotics, Prebiotics, and New Food, September 7–9, 2003) was to provide an objective view of the regulatory trends at the European level specifically referring to probiotics, because until now they have never been directly mentioned nor officially or expressly regulated per food and/or dietary applications, excluding their use as “active principles” in pharmaceutical products. Such a report presented during a scientific congress could represent a potential link between the world of research and the world of industry, both of presently deeply engaged and attracted by the potentiality raised until now, as per the application of probiotics under different points of view. From Probiotical srl, a company of the Mofin Alce Group, Novara, Italy. Received for publication January, 13, 2004; accepted February 10, 2004. Reprints: Michela Bianco Prevot, Probiotical srl, Via Mattei n.3, 28100 Novara, Italy (e-mail: firstname.lastname@example.org). Editor’s Note: This presentation was made at the Rome meeting to explain Italian and European potential controls. It is not edited by the Journal because its content refers to European regulations. © 2004 Lippincott Williams & Wilkins, Inc.